Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Collaborative Health Research Projects

McMaster University

$114,580.00

Developing Thermally Stable Dry Powder Vaccine Platforms Via Spray Drying Tailored for Inhalation Delivery **

EF 2018-19

Résumé
Innovations in vaccine development greatly benefit public health, by pursuing new and*improved biologics, and re-envisioning new delivery routes though changes in their*formulation and manufacture. The proposed research will advance recent progress made by*an interdisciplinary team of scientists in designing new thermally stable vaccine platforms*targeted against tuberculosis and influenza infection, where the temperature sensitive*biologics will be stabilized by encapsulation in suitable carriers, thereby removing the*necessity for costly and often unavailable refrigeration equipment in their storage and*transport. The proposed project brings together chemical engineering and biomedical*expertise to understand and implement industrially relevant drying techniques that will*produce thermostable dry powder vaccines retaining their immune-boosting potency as seen*in their original liquid form, yet now can be stored at room temperature for 3 months without*loss in activity whereas liquid losses in potency occur in less than 1 week. Spray-drying these*vaccine powders under optimized conditions results in a product designed for delivery to the*lung by inhalation, boosting their effectiveness against lung-borne infections like tuberculosis*and influenza, while avoiding the complex logistics of re-constituting dried vaccines in liquid*media prior to administration. The research will produce optimal examples of thermostable*dry powder tuberculosis and influenza vaccines, relating their physical and biological*properties to engineering principles on particle formation and particle aerodynamics in the*human respiratory system. The new knowledge will be transferred to appropriate*pharmaceutical experts for the benefit of Canadas public health.
Programme
Collaborative Health Research Projects
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
523837-2018
Name nom
Thompson, Michael
Department département
Chemical Engineering
Organization id
27
Institution établissement
McMaster University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2018
Award amount
114580
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Partie
1
Nb partie
1
Application title
Developing Thermally Stable Dry Powder Vaccine Platforms Via Spray Drying Tailored for Inhalation Delivery **
Keyword
NSERC
Application summary
Innovations in vaccine development greatly benefit public health, by pursuing new and*improved biologics, and re-envisioning new delivery routes though changes in their*formulation and manufacture. The proposed research will advance recent progress made by*an interdisciplinary team of scientists in designing new thermally stable vaccine platforms*targeted against tuberculosis and influenza infection, where the temperature sensitive*biologics will be stabilized by encapsulation in suitable carriers, thereby removing the*necessity for costly and often unavailable refrigeration equipment in their storage and*transport. The proposed project brings together chemical engineering and biomedical*expertise to understand and implement industrially relevant drying techniques that will*produce thermostable dry powder vaccines retaining their immune-boosting potency as seen*in their original liquid form, yet now can be stored at room temperature for 3 months without*loss in activity whereas liquid losses in potency occur in less than 1 week. Spray-drying these*vaccine powders under optimized conditions results in a product designed for delivery to the*lung by inhalation, boosting their effectiveness against lung-borne infections like tuberculosis*and influenza, while avoiding the complex logistics of re-constituting dried vaccines in liquid*media prior to administration. The research will produce optimal examples of thermostable*dry powder tuberculosis and influenza vaccines, relating their physical and biological*properties to engineering principles on particle formation and particle aerodynamics in the*human respiratory system. The new knowledge will be transferred to appropriate*pharmaceutical experts for the benefit of Canadas public health.